Published in Life Sci on November 04, 2010
Prenatal Alcohol Exposure and the Developing Immune System. Alcohol Res (2015) 0.80
The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. J Neuroimmune Pharmacol (2015) 0.77
An examination of sex differences in the effects of early-life opiate and alcohol exposure. Philos Trans R Soc Lond B Biol Sci (2016) 0.76
Impact of cocaine abuse on HIV pathogenesis. Front Microbiol (2015) 0.76
Maternal cocaine use during breastfeeding. Can Fam Physician (2012) 0.75
Opioids and Viral Infections: A Double-Edged Sword. Front Microbiol (2016) 0.75
Accounting for dropout reason in longitudinal studies with nonignorable dropout. Stat Methods Med Res (2015) 0.75
Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages. Front Microbiol (2015) 0.75
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci (2007) 5.62
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr (2009) 3.88
The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2007) 3.76
Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis (2008) 3.48
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis (2007) 3.30
HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health (1993) 3.05
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med (1987) 2.91
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol (2006) 2.81
Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81
Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr (2006) 2.78
Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res (2003) 2.32
Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol (2002) 2.29
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28
Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr (2009) 2.17
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis (2003) 2.16
Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS (1991) 2.07
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med (2003) 2.02
Consequences of alcohol consumption on host defence. Alcohol Alcohol (2000) 1.97
HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr (2002) 1.97
Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol (1998) 1.91
Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. J Acquir Immune Defic Syndr (2005) 1.85
Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health (2006) 1.82
Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction (2007) 1.77
Metamphetamine use linked to rising HIV transmission. Lancet (2005) 1.75
Heart disease, methamphetamine and AIDS. Life Sci (2003) 1.75
Opioids, opioid receptors, and the immune response. Drug Alcohol Depend (2001) 1.72
Update on perinatal HIV transmission. Pediatr Clin North Am (2000) 1.71
The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sex Transm Dis (2004) 1.65
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61
Methamphetamine enhances HIV infection of macrophages. Am J Pathol (2008) 1.60
Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr (2004) 1.59
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology (2003) 1.51
Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ (2001) 1.49
Alcohol use in HIV patients: what we don't know may hurt us. Int J STD AIDS (1999) 1.48
In vitro studies of the effect of methadone on natural killer cell activity. Isr J Med Sci (1990) 1.46
Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction (2004) 1.43
The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques. Alcohol Clin Exp Res (2003) 1.41
Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol (2006) 1.37
Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol (1992) 1.36
Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol (2002) 1.35
Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis (2002) 1.33
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (2005) 1.32
Injection drug use and human immunodeficiency virus infection. Clin Infect Dis (1995) 1.31
Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol (1991) 1.31
Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis (1993) 1.29
Alcohol's contribution to compromised immunity. Alcohol Health Res World (1997) 1.27
Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health (2001) 1.27
Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis (1993) 1.23
Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol (2004) 1.23
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med (2002) 1.23
Teratogenic effects of alcohol on infant development. Alcohol Clin Exp Res (1993) 1.22
Opioid and opiate immunoregulatory processes. Crit Rev Immunol (1996) 1.19
Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. J Infect Dis (1996) 1.19
Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem (2002) 1.19
Opiates and infection. J Neuroimmunol (1998) 1.17
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med (1994) 1.17
Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol (2002) 1.16
Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol (1994) 1.16
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther (1989) 1.16
Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol (2005) 1.16
Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin Exp Res (2007) 1.16
Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol (2008) 1.16
Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. Pediatrics (1995) 1.15
Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcohol Clin Exp Res (1989) 1.14
Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol (2007) 1.13
Morphine enhances HIV infection of neonatal macrophages. Pediatr Res (2003) 1.13
Addiction in pregnancy. J Addict Dis (2010) 1.12
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003. Int J Drug Policy (2010) 1.11
HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men. J Addict Dis (2005) 1.11
Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol (2005) 1.11
Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol (1997) 1.10
Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques. AIDS Res Hum Retroviruses (2006) 1.10
Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am J Pathol (2010) 1.09
Ethanol and the placenta: A review. J Matern Fetal Neonatal Med (2007) 1.09
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08
Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol (1990) 1.07
Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res (2002) 1.06
Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A (2005) 1.04
Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis (2001) 1.04
Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med (2007) 1.04
Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol (2005) 1.04
Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol (2004) 1.03
Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol (1994) 1.02
The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol (2002) 1.02
Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology (1999) 1.01
Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model. J Acquir Immune Defic Syndr (2009) 1.00
Alcohol abuse and stage of HIV disease in intravenous drug abusers. J R Soc Med (1996) 1.00
Consequences of opiate-dependency in a monkey model of AIDS. Adv Exp Med Biol (1993) 0.98
Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Adv Biochem Psychopharmacol (1988) 0.98
Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res (2008) 0.98
Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS (1994) 0.97
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96
Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem (2003) 0.95
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96
Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol (2009) 1.74
Methamphetamine enhances HIV infection of macrophages. Am J Pathol (2008) 1.60
Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. Hepatology (2005) 1.31
Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol (2003) 1.25
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med (2002) 1.23
Quantification of CCR5 mRNA in human lymphocytes and macrophages by real-time reverse transcriptase PCR assay. Clin Diagn Lab Immunol (2003) 1.21
Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol (2004) 1.21
Morphine enhances HIV infection of neonatal macrophages. Pediatr Res (2003) 1.13
Alcohol potentiates hepatitis C virus replicon expression. Hepatology (2003) 1.11
Expression and regulation of antiviral protein APOBEC3G in human neuronal cells. J Neuroimmunol (2008) 1.08
Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08
Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res (2002) 1.06
Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis (2001) 1.04
Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro. J Neuroimmune Pharmacol (2007) 1.03
IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PLoS One (2012) 1.02
Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res (2008) 1.02
Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophages. J Neuroimmune Pharmacol (2008) 0.99
Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N). J Neurochem (2003) 0.97
Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia (2004) 0.97
Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA. Clin Diagn Lab Immunol (2005) 0.97
Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clin Diagn Lab Immunol (2002) 0.96
Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes. J Leukoc Biol (2006) 0.95
Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines. AIDS (2004) 0.95
Molecular epidemiology of astrovirus infection in infants in Wuhan, China. J Clin Microbiol (2007) 0.93
NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol (2006) 0.91
Opioids and HIV/HCV infection. J Neuroimmune Pharmacol (2011) 0.91
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists. J Leukoc Biol (2013) 0.90
Drug abuse, innate immunity and hepatitis C virus. Rev Med Virol (2006) 0.90
Morphine withdrawal enhances hepatitis C virus replicon expression. Am J Pathol (2005) 0.90
A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes. J Neuroimmunol (2002) 0.88
Interleukin-1beta induces macrophage inflammatory protein-1beta expression in human hepatocytes. Cell Immunol (2003) 0.88
M. tuberculosis H37Rv infection of Chinese rhesus macaques. J Neuroimmune Pharmacol (2010) 0.88
Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses. Vaccine (2007) 0.88
Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells. J Leukoc Biol (2005) 0.87
CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells. J Infect Dis (2005) 0.87
Identification of new subtype of astrovirus type 3 from an infant with diarrhea in Wuhan, China. Virology (2008) 0.84
Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication. J Infect Dis (2007) 0.84
Morphine suppresses intracellular interferon-alpha expression in neuronal cells. J Neuroimmunol (2008) 0.83
Nested RT-PCR. Sensitivity controls are essential to determine the biological significance of detected mRNA. Methods Mol Biol (2002) 0.82
Morphine upregulates functional expression of neurokinin-1 receptor in neurons. J Neurosci Res (2006) 0.81
An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. Am J Pathol (2006) 0.80
Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages. J Neuroinflammation (2011) 0.80
Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs. J Neuroimmune Pharmacol (2015) 0.79
Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells. Antiviral Res (2006) 0.79
CD56+ T cells inhibit HIV-1 infection of macrophages. J Leukoc Biol (2012) 0.79
Non-Human Primate Models of Tuberculosis. Microbiol Spectr (2016) 0.78
(-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes. Sci Rep (2016) 0.78
Mimic-based RT-PCR quantitation of substance P mRNA in human mononuclear phagocytes and lymphocytes. Methods Mol Biol (2002) 0.77
Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages. AIDS Res Hum Retroviruses (2013) 0.77
Alcohol suppresses IL-2-induced CC chemokine production by natural killer cells. Alcohol Clin Exp Res (2005) 0.76
Antiretroviral Therapy Fails to Restore Levels of HIV-1 Restriction miRNAs in PBMCs of HIV-1-infected MSM. Medicine (Baltimore) (2015) 0.75
Magnetic resonance imaging study of a simian/human immunodeficiency virus-infected Chinese rhesus macaque with HIV-associated dementia. AIDS Res Hum Retroviruses (2015) 0.75
Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection. J Acquir Immune Defic Syndr (2017) 0.75
CCR5 expression and beta-chemokine production during placental neonatal monocyte differentiation. Pediatr Res (2003) 0.75
Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages. Sci Rep (2016) 0.75